Clinical Trial: Evaluation of 627 in Healthy Adult Subjects

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07065136) titled 'Evaluation of 627 in Healthy Adult Subjects' on April 22.

Brief Summary: This is a randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose phase I clinical study to evaluate the safety, tolerability, PK and immunogenicity of SSGJ-627 in healthy adult subjects after single subcutaneous injection.

Study Start Date: July 20

Study Type: INTERVENTIONAL

Condition: Healthy Subjects (HS)

Intervention: BIOLOGICAL: 627

subcutaneous injection

OTHER: Placebo

Single subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Publis...